Skip to content

Tuesday, November 28, 2023

Latest:

Baylor surgeon treats rare condition
Exploring the complexity of ethics and Artificial Intelligence: Reflections and responsibilities
Gobble up your Thanksgiving turkey with these healthy cooking tips
Human mini guts reveal new insights into Cronkhite-Canada syndrome and potential new therapies
How to enjoy this season without taking a holiday from healthy eating

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Akt pathway

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021February 23, 2021 Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

CD44s, not CD44v, contributes to cancer survival

July 25, 2017May 11, 2018 Akt pathway, alternative splicing, cancer survival, CD44, EGFR signaling

Cells may stray away from their normal function in a number of ways. For example, it’s been known for some time that in a number

From the Labs Image of the Month

From the Labs: Neural connections in the visual pathway of the brain

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951